CDX1 is an important molecular mediator of Barrett's metaplasia.
The molecular pathogenesis of Barrett's metaplasia (BM) of the esophagus is poorly understood. The change to an intestinal phenotype occurs on a background of esophagitis due to refluxing acid and bile. CDX1, an important regulator of normal intestinal development, was studied as a potential ke...
Asıl Yazarlar: | Wong, N, Wilding, J, Bartlett, S, Liu, Y, Warren, B, Piris, J, Maynard, N, Marshall, R, Bodmer, W |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2005
|
Benzer Materyaller
-
EpCAM and gpA33 are markers of Barrett's metaplasia.
Yazar:: Wong, N, ve diğerleri
Baskı/Yayın Bilgisi: (2006) -
Immunohistochemical Expression of CDX2 in Gastroesophageal Junction Biopsies: An Emerging Marker for Early Intestinal Differentiation of Barrett’s Metaplasia
Yazar:: Twisha Adhikari, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01) -
Barrett’s Esophagus and Intestinal Metaplasia
Yazar:: Lu Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01) -
The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry
Baskı/Yayın Bilgisi: (2012-01-01) -
Immunohistochemical study of epithelial-myofibroblast interaction in Barrett metaplasia
Yazar:: Ochicha O, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)